Abstract
Cutaneous vasculitis is a group of clinical diseases characterized by angiocentric segmental inflammation, endothelial cell swelling, and fibrinoid necrosis of blood vessel walls. They can be idiopathic, associated with an underlying disease, or can be precipitated by drugs and infections. Even if skin lesions are various, the commonest is palpable purpura. Some patients show symptoms of a systemic vascular involvement. Evaluation of patient includes a thorough history, physical examination, laboratory screening, and histopathology studies. The ideal therapeutic approach is to find out and remove the causative agent. When it is not possible, local and systemic treatments are necessary.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hautmann G, Campanile G, Lotti TM. The many faces of cutaneous vasculitis. Clin Dermatol. 1999;17(5):515–31.
Kawakami T. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J Dermatol. 2010;37(2):113–24.
Lotti TM, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Relation to systemic disease. Adv Exp Med Biol. 1999;455:115–25.
Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–84.
Further Reading
Barnadas MA, Pérez E, Gich I, et al. Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis. Int J Dermatol. 2004;43:19–26.
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27:504–28.
Conforti G, Cannavò SP, Jafferany M, et al. Coronavirus disease 2019: facts and controversies. Dermatol Ther. 2020;33:e13366.
Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol. 2003;48:311–40.
Ishibashi M, Chen KR. A morphological study of evolution of cutaneous polyarteritisnodosa. Am J Dermatopathol. 2008;30:319–26.
Loricera J, Blanco R, Ortiz-Sanjuán F, et al. Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases. Rheumatology. 2015;54:77–82.
Marneros AG, Blanco F, Husain S, et al. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels. J Am Acad Dermatol. 2009;60:633–8.
Ramos-Casals M, Perez-Alvarez R, Diaz-Lagares C, et al. Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev. 2010;9:188–93.
Tsampau D, Buggiani G, Hercogova J, Lotti T. Cutaneous necrotizing vasculitis: a rational therapeutic approach. Dermatol Ther. 2012;25(4):335–9.
Wollina U, Krönert C, Koch A, et al. Erythema elevatum diutinum—two case reports, two different clinical presentations, and a short literature review. Open Access Maced J Med Sci. 2019;7(18):3039–42.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gianfaldoni, S., D’Erme, A.M., Hercogova, J., Lotti, T.M. (2023). Cutaneous Vasculitis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)